Approval · Notice of Compliance 15124 · 2014
AZITHROMYCIN: Notice of Compliance 15124
Issued January 15, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15124
- Date
- January 15, 2014
- Company
- Dominion PharmacalMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Licensing agreement between two companies
- Therapeutic class
- Antibacterial agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| AZITHROMYCIN | 02418363 | Cancelled Pre Market |
| AZITHROMYCIN | 02418371 | Cancelled Pre Market |
Medicinal ingredients
- AZITHROMYCIN 100 MG per 5ML
- AZITHROMYCIN 200 MG per 5ML